United States: In a breakthrough development, the Food and Drug Administration (FDA) on Tuesday approved Eli Lilly’s Alzheimer’s drug donanemab, which allowed the expansion of limited treatment alternatives that were available for the mind-wasting disease in the United States. The ...
United States: Although the shortage of Cisplatin and Carboplatin in the United States has been reduced, a new report has revealed that some of the largest cancer centers in the country admit to facing an additional shortage of certain drugs. ...